JAX Clinical Knowledgebase (JAX-CKB)
@JAX_CKB
JAX-CKB: #PrecisionMedicine platform by @jacksonlab for interpreting human #cancer variants, #genomics & #proteomics, to match to therapies and #clinicaltrials.
You might like
CKB's New #cancer variant navigation is out! Learn more here: ckbhome.jax.org/about/category…
📰 New on the JAX Blog: The task of finding variants that potentially contribute to drug resistance can be overwhelming. Read how the @JAX_CKB is an invaluable resource in identifying a list of potential resistance variants for preclinical testing: jax.org/news-and-insig…
Interesting study on how IL-17 can drive resistance to anti-PD-L1 treatment! #immunotherapy #cancerresearch #cytokines
Xing Chen et al. report that IL-17, a proinflammatory cytokine widely associated with poor prognosis in solid tumors, drives the therapeutic failure of anti–PD-L1. bit.ly/372UZ6f From our #Cancer #Immunotherapy collection: bit.ly/3UB7vxh #SITC22
#AMPath22 attendees, looking for a resource to interpret genomic variants and find treatment options and clinical trials? Come visit us at booth #940 and ask for a CKB demo! #ClinicalKnowledgebase #PrecisionMedicine #PathTwitter 🧬
Check out our latest blog post on how you can use CKB as a resource for preclinical drug testing! #AMPath22 attendees, visit us at booth 940 to learn more! resources.jax.org/jax-blog/jax-c… #cancerresearch #cancertreatments #PrecisionMedicine
Attending #AMP2022 this week? Come visit our booth, #940, to learn more about how CKB can be used for interpreting genomic variants and finding relevant treatments and #clinicaltrials! #precisionmedicine #genomics #CancerResearch
Early results from phase I ARROS-1 trial: NVL-520 in #ROS1 by Dr. @alexdrilon at #ENA2022. This novel ROS1 inhibitor is designed to avoid #NTRK (and TRK-related toxicities, which often limit dose intensity). Studied in a heavily pretreated population (71% with ≥2 TKIs and chemo)
Updates to CKB CORE and BOOST 👏! We've made some changes to improve search performance and enhance the search results for "Explore by Variant"! Check out this screenshot for--> #BRAFV600E in CKB CORE #CancerResearch #genomics #precisionmedicine
Are you attending #AMP2022? JAX-CKB will be there! Come visit us at booth #940 and learn how CKB can be used to interpret #cancer genomic profiles and identify treatment options! #precisionmedicine #cancerresearch #clinicaltrials
CKB CORE users--> the next quarterly update to the gene list is now available! This quarter's theme is the tumor suppressor genes! ckb.jax.org #cancerresearch #genomics
Check out this latest commentary on how to choose the best interpretation tools for your #oncology data! #precisionmedicine #genomics #CancerResearch bio-itworld.com/news/2022/10/1…
Check out our new publication: Remotely Guided Immunobots Engaged in Anti-Tumorigenic Phenotypes for Targeted Cancer Immunotherapy- where we convert live macrophages into robots for targeted immunoengineering. onlinelibrary.wiley.com/doi/full/10.10… @NihalOlcay @metin_sitti @MayoClinic @MPI_IS
"Scientists are developing numerous approaches to make [cancer] immunotherapy safer, including drafting different immune cells, like the awesomely-named natural killer cells. Another option is Calibr’s off switch." freethink.com/health/switcha…
A great updated summary from @theNCI highlighting the advances in #BreastCancer research! #BreastCancerAwarenessMonth #CancerResearch
Our recently updated summary of advances in #BreastCancer research highlights clinical advances that may soon translate into improved care as well as findings from recent studies. Check it out! cancer.gov/types/breast/r… #BCSM
Interesting study highlighting a new potential mechanism for resistance to immunotherapy -->cancer cells hiding within one another- "transient cell-in-cell structures" #immunotherapy #precisiononcology #CancerResearch doi.org/10.7554/eLife.…
Did you know a large portion of the evidence in CKB is #preclinical? Learn more about the types of preclinical data available in CKB in our latest blog post! #CancerResearch #genomics #PrecisionMedicine jax.org/news-and-insig…
Extensive review including the history of #immunotherapy, currently available treatment options, and future therapeutic targets across multiple #cancer types! @NaturePortfolio #PrecisionMedicine #immunoOncology pubmed.ncbi.nlm.nih.gov/36123348/
Intriguing discussion of OMICS behind the #HER2low breast cancer by @prat_aleix at #ESMO22 ✅Luminal A/B subtypes enriched in HER2Low vs HER2-0 ✅Small difference between HER2-0 and HER2Low in ERBB2 mRNA expression ✅New diagnostic assays (mRNA?) needed @OncoAlert @myESMO
Looking forward to chairing this study with @MeghnaTrivedi3 and working with my @jacksonlab colleagues in @JAXClinicalEd and @JAX_CKB
Do more #CancerPatients get genome-informed #cancer treatment when a genomic tumor board helps doctors choose treatments? Study S2108CD is designed to answer this question. Learn more at SWOG.org/S2108CD. Or call 1-800-4-CANCER. Ask about S2108CD. #bcsm #LCSM #CRCSM
Exciting work going on for #KRAS #G12R-driven cancers! #cancerresearch #hotspotmutations
The to-do list is getting shorter. #G12R. The next #KRAS oncogene targeted by covalent chemistry. Great work @bignerdzzy @UCB_Chemistry @mo_hannes @ace_eckert @UCSF @HHMINEWS @UCSFCancer @acsJACS pubs.acs.org/doi/10.1021/ja…
Great overview of recent papers detailing the current treatment landscape and emerging #biomarkers in advanced hepatocellular carcinoma. @CCR_AACR #HCC #PrecisionMedicine #oncology pubmed.ncbi.nlm.nih.gov/35727695/
United States Trends
- 1. Epstein 474K posts
- 2. Steam Machine 10.1K posts
- 3. Virginia Giuffre 18.9K posts
- 4. Rosalina 51.4K posts
- 5. #NASDAQ_NXXT N/A
- 6. Brie Larson 19.1K posts
- 7. #NASDAQ_MYNZ N/A
- 8. Bowser Jr 16K posts
- 9. Boebert 4,376 posts
- 10. Steam Frame 8,404 posts
- 11. H-1B 82.5K posts
- 12. The Devil Wears Prada 2 30.9K posts
- 13. Michael Wolff 10.6K posts
- 14. AJ Brown 7,209 posts
- 15. Valve 9,995 posts
- 16. Jeezy 10.9K posts
- 17. Delaware 13.1K posts
- 18. Clinton 102K posts
- 19. Jameis 7,026 posts
- 20. MEDICA 2025 N/A
You might like
-
Nature Reviews Genetics
@NatureRevGenet -
FDA Oncology
@FDAOncology -
@gulleyj1
@gulleyj1 -
cBioPortal
@cbioportal -
Eli Van Allen
@VanAllenLab -
The Jackson Laboratory
@jacksonlab -
Foundation Medicine
@FoundationATCG -
Sid Yadav MD, FACP
@SidYadavMD -
Eric Minwei Liu
@EricM_Liu -
Wafik S. El-Deiry, MD, PhD, FACP
@weldeiry -
Cancer Genomics Consortium (CGC)
@CG_Consortium -
Nathan A. Pennell MD, PhD, FASCO
@n8pennell -
Razelle Kurzrock, MD
@Dr_R_Kurzrock -
Erica Mayer
@elmayermd -
Alessandro Russo
@Al3ssandroRusso
Something went wrong.
Something went wrong.